Abstract:BackgroundHyperglycemia has been reported to be associated with the outcomes of patients in the intensive care unit (ICU). However, the relationship between hemoglobin A1c (HbA1c) and long-term or short-term mortality in the ICU is still unknown. This study used the Medical Information Mart for Intensive Care (MIMIC)-IV database to investigate the relationship between HbA1c and long-term or short-term mortality among ICU patients without a diabetes diagnosis.MethodsA total of 3,154 critically ill patients without a diabetes diagnosis who had HbA1c measurements were extracted and analyzed from the MIMIC-IV. The primary outcome was 1-year mortality, while the secondary outcomes were 30-day mortality and 90-day mortality after ICU discharge. HbA1c levels were classified into four levels according to three HbA1c values (5.0%, 5.7%, and 6.5%). The Cox regression model was used to investigate the relationship between the highest HbA1c measurement and mortality. Finally, this correlation was validated using the XGBoost machine learning model and Cox regression after propensity score matching (PSM).ResultsThe study eventually included 3,154 critically ill patients without diabetes who had HbA1c measurements in the database. HbA1c levels of below 5.0% or above 6.5% were significantly associated with 1-year mortality after adjusting for covariates in Cox regression (HR: 1.37; 95% CI: 1.02–1.84 or HR: 1.62; 95% CI: 1.20–2.18). In addition, HbA1c 6.5% was linked to 30-day mortality (HR: 1.81; 95% CI: 1.21–2.71) and 90-day mortality (HR: 1.62; 95% CI: 1.14–2.29). The restricted cubic spline demonstrated a U-shaped relationship between HbA1c levels and 1-year mortality. The AUCs of the training and testing datasets in the XGBoost model were 0.928 and 0.826, respectively, while the SHAP plot revealed that HbA1c was somewhat important for the 1-year mortality. Higher HbA1c levels in Cox regression were still significantly associated with 1-year mortality after PSM for other factors,ConclusionsThe 1-year mortality, 30-day mortality, and 90-day mortality rates for critically ill patients after discharge from ICU are significantly associated with HbA1c. HbA1c < 5.0% and ≥6.5% would increase 30-day, 90-day, and 1-year mortality, while levels between 5.0% and 6.5% of HbA1c did not significantly affect these outcomes.

Higher Hemoglobin A1c Level is Associated with Poor Outcome of Intracerebral Hemorrhage.

Elevated Serum HbA1c Level, Rather Than Previous History of Diabetes, Predicts the Disease Severity and Clinical Outcomes of Acute Pancreatitis

Association Between Hemoglobin A(1c) Levels and Clinical Outcome in Ischemic Stroke Patients with or Without Diabetes

Association of glycosylated hemoglobin level at admission with outcomes of intracerebral hemorrhage patients

Association Between Elevated Hemoglobin A1c Levels and the Outcomes of Patients with Small-Artery Occlusion: A Hospital-Based Study.

Relationship Between Glycosylated Hemoglobin and Short-Term Mortality of Spontaneous Intracerebral Hemorrhage

Hemoglobin A1c Predicts Hemorrhagic Transformation and Poor Outcomes after Acute Anterior Stroke.

Prognostic Significance of Hyperglycemia in Acute Intracerebral Hemorrhage the Interact2 Study

Effect of Admission Hyperglycemia on 6-Month Functional Outcome in Patients with Spontaneous Cerebellar Hemorrhage

Relationship Between Acute Hyperglycemia and Prognosis in Patients Following Spontaneous Intracerebral Hemorrhage

The relationship between HbA1c and the activities of daily living in complex chronic patients with and without intracerebral hemorrhage

Association Between Glycated Albumin and Adverse Outcomes in Patients with Heart Failure.

Association between HbA1c levels with severity of coronary artery disease and short-term outcomes of acute ST-elevation myocardial infarction in nondiabetic patients

The Association Between Hemoglobin A1c and All-Cause Mortality in the ICU: A Cross-Section Study Based on MIMIC-IV 2.0.

Is Diabetes a Predictor of Worse Outcome for Spontaneous Intracerebral Hemorrhage?

Glucose Levels and Outcome after Primary Intraventricular Hemorrhage.

Hemoglobin A1C is independently associated with severity and prognosis of brainstem infarctions.

Glycosylated Hemoglobin A1c Predicts Intracerebral Hemorrhage with Acute Ischemic Stroke Post-Mechanical Thrombectomy

Association of glycemic control with mortality in patients with diabetes mellitus undergoing percutaneous coronary intervention

Prognostic Implication of Admission HbA1c for All-cause Mortality in Ischemic Heart Failure among a Chinese Population: A Prospective Cohort Study

Association of Blood Glucose with 30-Day Mortality in Patients with Intracerebral Hemorrhage Undergoing Neurosurgical Treatment